Oxford BioDynamics posts loss as revenue falls, costs rise
Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Biomarker company Oxford BioDynamics posted a first-half loss after revenue fell and costs rose.

Pre-tax losses for the six months through March amounted to £2.3m, compared to losses of £1.6m on-year.

Revenue slipped to £0.2m, back from £0.6m, while R&D and staff costs both increased.

  •